MARKET DRAYTON MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: M82010 | MARKET DRAYTON, TF9 3AL
Showing results 101-150 of 734
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mebeverine hydrochloride | 678 | 63.7K | £4.6K | +118.4% ▲ |
| Estradiol | 678 | 151.7K | £23.1K | -17.4% ▼ |
| Oxycodone hydrochloride | 676 | 60.1K | £9.7K | +164.1% ▲ |
| Spironolactone | 672 | 28.8K | £2.0K | +24.6% ▲ |
| Felodipine | 670 | 33.6K | £5.3K | +12.8% ▲ |
| Levetiracetam | 657 | 79.8K | £10.6K | +43.5% ▲ |
| Edoxaban | 655 | 28.6K | £47.5K | -6.5% ▼ |
| Hyoscine butylbromide | 646 | 50.6K | £3.9K | +177.2% ▲ |
| Fluticasone furoate/vilanterol | 637 | 1,088 | £26.2K | +311.5% ▲ |
| Ibuprofen | 632 | 60.6K | £2.1K | +24.3% ▲ |
| Ready to serve 1.5 kcal/ml milkshake (0913011) | 631 | 4.5M | £30.1K | +344.0% ▲ |
| Perindopril erbumine | 627 | 33.7K | £2.8K | +18.1% ▲ |
| Quinine sulfate | 623 | 26.6K | £3.7K | +115.2% ▲ |
| Irbesartan | 621 | 34.0K | £1.6K | +154.9% ▲ |
| Ferrous fumarate | 621 | 45.9K | £2.1K | -14.3% ▼ |
| 618 | 86.9K | £3.9K | +30.3% ▲ | |
| Empagliflozin | 614 | 25.8K | £32.1K | -1.9% vs avg |
| Glyceryl trinitrate | 595 | 2,003 | £1.6K | +151.6% ▲ |
| Prochlorperazine maleate | 595 | 37.4K | £2.6K | +194.4% ▲ |
| 589 | 610 | £3.0K | +149.4% ▲ | |
| Carbamazepine | 583 | 80.8K | £4.3K | +96.5% ▲ |
| Escitalopram | 581 | 29.5K | £3.0K | +104.1% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 580 | 97.5K | £8.2K | +156.6% ▲ |
| Lisinopril | 571 | 32.4K | £714 | -47.9% ▼ |
| Esomeprazole | 567 | 35.5K | £2.8K | +40.1% ▲ |
| Fluticasone furoate | 565 | 658 | £4.2K | +191.7% ▲ |
| Cetirizine hydrochloride | 561 | 43.4K | £1.8K | +12.3% ▲ |
| Fluticasone/umeclidinium/vilanterol | 560 | 796 | £33.7K | +138.9% ▲ |
| Mometasone furoate | 544 | 32.8K | £3.2K | +306.8% ▲ |
| Lorazepam | 527 | 19.0K | £4.9K | +269.7% ▲ |
| Estradiol | 527 | 13.3K | £7.7K | +95.3% ▲ |
| 518 | 17.9K | £6.2K | +569.9% ▲ | |
| Nifedipine | 517 | 36.1K | £6.8K | +175.9% ▲ |
| Betahistine hydrochloride | 506 | 51.7K | £1.9K | +111.9% ▲ |
| Sodium valproate | 501 | 55.0K | £12.0K | +57.5% ▲ |
| Sacubitril/valsartan | 474 | 37.2K | £60.9K | +97.9% ▲ |
| Calcipotriol | 462 | 48.6K | £29.2K | +171.4% ▲ |
| Methotrexate | 458 | 14.7K | £879 | +40.7% ▲ |
| Dexamethasone | 457 | 2,380 | £1.5K | +165.8% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 449 | 15.8K | £1.5K | +194.0% ▲ |
| 445 | 5,075 | £1.4K | +112.9% ▲ | |
| Desogestrel | 440 | 72.5K | £2.2K | +11.0% ▲ |
| Loperamide hydrochloride | 434 | 39.4K | £993 | +86.3% ▲ |
| Diltiazem hydrochloride | 429 | 35.4K | £5.5K | +39.7% ▲ |
| Mometasone furoate | 424 | 505 | £3.9K | +5.6% ▲ |
| Linagliptin | 421 | 15.8K | £17.9K | +2.8% ▲ |
| Melatonin | 415 | 27.0K | £13.0K | +24.8% ▲ |
| Donepezil hydrochloride | 415 | 13.4K | £1.0K | +34.5% ▲ |
| Memantine hydrochloride | 415 | 14.6K | £2.6K | +25.6% ▲ |
| Umeclidinium bromide/vilanterol | 413 | 604 | £18.7K | +111.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.